This company listing is no longer active
600090 Stock Overview
XIN JIANG READY HEALTH INDUSTRY Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
XIN JIANG READY HEALTH INDUSTRY Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥0.27 |
| 52 Week High | CN¥1.76 |
| 52 Week Low | CN¥0.27 |
| Beta | 0.26 |
| 11 Month Change | -71.88% |
| 3 Month Change | -73.27% |
| 1 Year Change | -84.21% |
| 33 Year Change | -94.04% |
| 5 Year Change | -97.01% |
| Change since IPO | -97.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600090 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 0% | -4.8% | -6.7% |
| 1Y | -84.2% | -16.6% | 1.9% |
Return vs Industry: 600090 underperformed the CN Healthcare industry which returned -27.4% over the past year.
Return vs Market: 600090 underperformed the CN Market which returned -8.1% over the past year.
Price Volatility
| 600090 volatility | |
|---|---|
| 600090 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 600090's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 600090's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 821 | Qing Li | www.cnready.com |
XIN JIANG READY HEALTH INDUSTRY Co., Ltd. engages in the medicines and equipment solutions for medical institutions, wholesale companies, and retail pharmacies in China. The company offers bio-pharmacy and agriculture products, and fruit and vegetable drinks.
XIN JIANG READY HEALTH INDUSTRY Co., Ltd. Fundamentals Summary
| 600090 fundamental statistics | |
|---|---|
| Market cap | CN¥388.65m |
| Earnings (TTM) | -CN¥2.39b |
| Revenue (TTM) | n/a |
-0.3x
P/S Ratio-0.2x
P/E RatioIs 600090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600090 income statement (TTM) | |
|---|---|
| Revenue | -CN¥1.18b |
| Cost of Revenue | -CN¥1.04b |
| Gross Profit | -CN¥142.36m |
| Other Expenses | CN¥2.24b |
| Earnings | -CN¥2.39b |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.66 |
| Gross Margin | 12.04% |
| Net Profit Margin | 201.68% |
| Debt/Equity Ratio | 29.3% |
How did 600090 perform over the long term?
See historical performance and comparison